Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

zoledronate

Known as: (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid, [1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic Acid, NDC-Zoledronate 
The brand name for zoledronic acid, a bisphosphonic imidazol compound which inhibits osteoclastic bone resorption. Although its mechanisms of action… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Chagas cardiomyopathy is the most frequent and most severe manifestation of chronic Chagas disease, and is one of the leading… Expand
  • table III
  • table IV
  • table V
  • table VI
Is this relevant?
Review
2016
Review
2016
BACKGROUND Based on preclinical data for the antitumour effect of zoledronate in osteosarcoma, we assessed whether zoledronate… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Aromatase inhibitors are the preferred adjuvant endocrine therapy for the majority of postmenopausal women with… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Bisphosphonates (BPs) effectively treat metastatic bone disease, hypercalcemia, and osteoporosis. BP exposure, however… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Human gammadelta T cells can be activated by phospho-antigens and aminobisphosphonates such as zoledronate. Because… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The increasing evidence that gammadelta T cells have potent antitumor activity suggests their value in immunotherapy… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2007
Review
2007
SummaryBisphosphonates (BPs) are well established as the leading drugs for the treatment of osteoporosis. There is new knowledge… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
2003
Highly Cited
2003
  • Robert E. Marx
  • Journal of oral and maxillofacial surgery…
  • 2003
  • Corpus ID: 13516453
 
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Renal failure and toxic acute tubular necrosis (ATN) may be seen following exposure to a variety of therapeutic agents… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Zolensky ME, and McSween, HY Jr (1988) Aqueous alteration. In Meteorites and the Early Solar System (JF KCITIdge, MS Matthews cds… Expand
  • figure 1
  • figure 2
  • table 2
  • figure 3
  • table 6
Is this relevant?